Christopher S. Keenan
Nessuna posizione attualmente
Profilo
Christopher S.
Keenan held positions in investor relations and corporate communications at Avid Bioservices, Cytokinetics, Assertio Therapeutics, and CytomX Therapeutics.
Precedenti posizioni note di Christopher S. Keenan
| Società | Posizione | Fine |
|---|---|---|
| AVID BIOSERVICES, INC. | Public Communications Contact | 01/06/2015 |
| CYTOMX THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Contatto Relazioni con gli Investitori | - |
| CYTOKINETICS, INCORPORATED | Contatto Relazioni con gli Investitori | 31/10/2011 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| AVID BIOSERVICES, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
- Borsa valori
- Insiders
- Christopher S. Keenan
